Duval, FlorentDe Palma, Michele2019-07-172019-07-172019-07-172019-07-0110.1158/2159-8290.CD-19-0535https://infoscience.epfl.ch/handle/20.500.14299/159161WOS:000473530600015Macrophages modulate tumor response to chemotherapy; in this issue, Lossos and colleagues show that high-dose alkylating agents instigate a synthetic lethal program in lymphoma cells that is independent of DNA damage and involves recruitment and priming of macrophages for antibody-mediated tumor phagocytosis. These fi ndings implicate chemotherapy-elicited macrophages as critical effectors of lymphoma clearance during biological therapy.See related article by Lossos et al., p. 944 (3).OncologyLymphoma Chemotherapy: Hungry Macrophages Strike the Final Blowtext::journal::journal article::research article